A detailed history of Edgestream Partners, L.P. transactions in Quidel Ortho Corp stock. As of the latest transaction made, Edgestream Partners, L.P. holds 58,404 shares of QDEL stock, worth $2.66 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
58,404
Previous 19,175 204.58%
Holding current value
$2.66 Million
Previous $919,000 111.1%
% of portfolio
0.09%
Previous 0.05%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$32.9 - $47.0 $1.29 Million - $1.84 Million
39,229 Added 204.58%
58,404 $1.94 Million
Q1 2024

May 10, 2024

BUY
$41.76 - $74.73 $800,748 - $1.43 Million
19,175 New
19,175 $919,000
Q2 2023

Aug 10, 2023

BUY
$81.09 - $94.16 $789,167 - $916,365
9,732 New
9,732 $806,000
Q3 2022

Nov 14, 2022

BUY
$69.86 - $107.63 $2.78 Million - $4.28 Million
39,739 Added 533.55%
47,187 $3.37 Million
Q2 2022

Aug 12, 2022

BUY
$89.06 - $117.64 $663,318 - $876,182
7,448 New
7,448 $724,000

Others Institutions Holding QDEL

About QuidelOrtho Corp


  • Ticker QDEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 66,952,900
  • Market Cap $3.05B
  • Description
  • QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tes...
More about QDEL
Track This Portfolio

Track Edgestream Partners, L.P. Portfolio

Follow Edgestream Partners, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edgestream Partners, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Edgestream Partners, L.P. with notifications on news.